In vivo and clinical data further confirm that SEC61G expression correlates with M2 polarization and reduced anti-tumor immune activity, as seen in enhanced CD206 expression and decreased CD8+ T cell infiltration in high-SEC61G conditions. This evidence concerns the gene SEC61G and neoplasm.